Previous 10 | Next 10 |
Co-Diagnostics, Inc. (CODX) Q1 2022 Earnings Conference Call May 12, 2022, 16:30 ET Company Participants Andrew Benson - Head, IR Dwight Egan - Chairman, CEO & President Brian Brown - CFO & Company Secretary Conference Call Participants Yi Chen - H.C. Wainwright & Co. James Sidoti...
Co-Diagnostics (NASDAQ:CODX) is up 11% in post-market trading after the company's Q1 2022 results beat on the top and bottom lines. Net income of $11.7M ($0.34 per share diluted) was a 48% increase compared to the prior-year period. Revenue of $22.7M, a ~13% year-over-year incr...
Co-Diagnostics press release (NASDAQ:CODX): Q1 GAAP EPS of $0.34 beats by $0.17. Revenue of $22.7M (+13.4% Y/Y) beats by $1.53M. CEO comment: "Looking forward, we are focused on completing development and FDA submission of the new platform. Our strong balance sheet and liquidity continue to p...
Co-Diagnostics Reports Solid First Quarter 2022 Financial Results PR Newswire Strong results highlighted by record first quarter revenue of $22.7 million and diluted EPS of $0.34 SALT LAKE CITY , May 12, 2022 /PRNewswire/ -- Co-Diagn...
Co-Diagnostics, Inc. to Host Booth at Medical Fair Brasil 2022 in São Paulo on May 3-6 PR Newswire SALT LAKE CITY , May 3, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx,"), a molecular diagnostics company with...
CO-DIAGNOSTICS, INC. ANNOUNCES FIRST QUARTER 2022 EARNINGS RELEASE DATE AND WEBCAST PR Newswire SALT LAKE CITY , April 28, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the d...
Co-Diagnostics, Inc. to Host Booth at ECCMID 2022 in Lisbon, Portugal on April 23-26 PR Newswire SALT LAKE CITY , April 22, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx,"), a molecular diagnostics company with a u...
Molecular diagnostics company Co-Diagnostics (NASDAQ:CODX) on Tuesday said its JV for manufacturing and sales in India has received Indian regulatory approval to make and sell CODX's SARAQ Hepatitis C Viral Load Kit as an in vitro diagnostic. CODX's JV CoSara Diagnostics was given the clearan...
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Hepatitis C Viral Load Test PR Newswire SALT LAKE CITY , April 19, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics comp...
Shares of Co-Diagnostics Inc. (NASDAQ:CODX) traded at a new 52-week high today of $31.57. This new high was reached on above average trading volume as 249.4 million shares traded hands, while the average 30-day volume is approximately 466,000 shares. Co-Diagnostics Inc. (NASDAQ:CODX) has...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago PR Newswire SALT LAKE CITY , July 29, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company wi...
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR Newswire SALT LAKE CITY , July 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company w...